Loading peptide directory…

Explore

All peptides
Healing & repair
Metabolic
Guides
Recent reviews
Lab COAs

For vendors

Vendor directory
Apply to be listed
Vendor agreement
How we rank vendors
Vendor API docs

Company

About
Contact
FAQ

Legal

Terms
Privacy
Content policy

AminoCatalog

Compounds discussed on this site are research chemicals, not for human consumption. The information here is editorial and has not been evaluated by the FDA.

Growth Hormone Secretagogues peptides · AminoCatalog

PeptidesGrowth Hormone Secretagogues

Growth Hormone Secretagogues

Compounds that stimulate endogenous growth hormone release.

10peptides in this category

CJC-1295 DAC

CJC1295 DACCJC-1295 with DACDAC-GRFDrug Affinity Complex GHRH analogmodified GHRH(1-29)

CJC-1295 DAC is a modified GHRH(1-29) analog engineered with a Drug Affinity Complex that covalently binds serum albumin after injection, extending its half-life to roughly 6–8 days. The retrieved literature includes randomized placebo-controlled ascending-dose trials in healthy humans showing sustained GH and IGF-1 elevation with preserved pulsatility.

Reference pageRead

Growth Hormone Secretagogues

GHRP-2

GHRP2Growth Hormone Releasing Peptide 2PralmorelinKP-102

GHRP-2 is a synthetic growth hormone secretagogue and ghrelin receptor agonist. The retrieved literature treats it primarily as a tool for studying GH secretion, appetite regulation, and growth physiology rather than as an established therapeutic drug.

Reference pageRead

Growth Hormone Secretagogues

GHRP-6

GHRP6Growth Hormone Releasing Peptide 6His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

GHRP-6 is a synthetic GH secretagogue hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, MW 872.44 Da). In humans it is concentrated in endocrine challenge tests, diagnostic protocols, and mechanistic studies — particularly as part of the GHRH/GHRP-6 test for adult GH deficiency — rather than in therapeutic outcome trials.

Reference pageRead

Growth Hormone Secretagogues

Hexarelin

ExamorelinEX-1HEX

Hexarelin is a potent synthetic growth-hormone secretagogue. Relative to ipamorelin it is less selective: it reliably stimulates GH but also stimulates prolactin, ACTH, and cortisol, giving it a stronger pharmacodynamic footprint and a rougher endocrine side-effect profile.

Reference pageRead

Growth Hormone Secretagogues

Human Growth Hormone

hGHrhGHSomatropinOmnitropeNorditropinGenotropinHumatrope

"Human growth hormone" in modern therapeutics refers to recombinant somatropin. Approved somatropin products such as Omnitrope cover pediatric growth hormone deficiency, Prader–Willi syndrome, small-for-gestational-age children, Turner syndrome, idiopathic short stature, and adult growth hormone deficiency. It is one of the most well-characterized peptide hormone therapies in modern endocrinology.

Reference pageRead

Growth Hormone Secretagogues

IGF-1 LR3

Long R3 IGF-1LR3 IGF-1Long [Arg3] IGF-1

IGF-1 LR3 is a synthetic 83-amino-acid analog of IGF-1 with an arginine substitution at position 3 plus a 13-amino-acid N-terminal extension. It is predominantly a research reagent; the retrieved literature did not identify a substantial clinical efficacy program in humans specific to LR3.

Reference pageRead

Growth Hormone Secretagogues

Ipamorelin

NNC 26-0161IPAM

Ipamorelin is a synthetic pentapeptide developed as a selective growth-hormone secretagogue. Its main pharmacologic attraction relative to hexarelin is selectivity: it stimulates GH cleanly and, in profiling work, does not materially raise ACTH or cortisol.

Reference pageRead

Growth Hormone Secretagogues

Mod GRF 1-29

CJC-1295 without DAC(D-Ala2,Gln8,Ala15,Leu27)-GRF amideModified GRF 1-29Stabilized GRF(1-29)

Mod GRF 1-29 is commonly treated as the same molecule as CJC-1295 without DAC — a short-acting, stabilized analog of the active N-terminal portion of GHRH. Peer-reviewed analytical literature identifies the molecule as (D-Ala2, Gln8, Ala15, Leu27)-GRF amide, distinguishing it from longer-acting DAC-containing forms.

Reference pageRead

Growth Hormone Secretagogues

Sermorelin

GerefGHRH(1-29)NH2GRF(1-29)NH2sermorelin acetate

Sermorelin is a synthetic analog of the first 29 amino acids of human growth hormone-releasing hormone (GHRH(1-29)NH2). It was FDA-approved as Geref for both GH-reserve diagnostic testing and pediatric growth hormone deficiency treatment; the FDA documented that the products were later withdrawn from sale, but not for reasons of safety or effectiveness.

Reference pageRead

Growth Hormone Secretagogues

Tesamorelin

Egrifta SVEgrifta WRtesamorelin acetateGHRF analog

Tesamorelin is a synthetic growth hormone-releasing factor analog, FDA-approved as Egrifta SV and Egrifta WR formulations for reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. The two formulations are explicitly not substitutable. It is not a general weight-loss drug.

Reference pageRead

Other categories

Healing & Repair
Cognitive & Nootropic
Metabolic

Other Research Peptides

Top vendors

Sample Research Supply
test
Admin Test Vendor

Related guides

Introduction to peptides
How to evaluate a peptide vendor
Storage and reconstitution basics